Printer Friendly

ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT; ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING

 ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT;


ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING
 MINNEAPOLIS, Aug. 31 /PRNewswire/ -- Richard D. Nikolaev, chairman and chief executive officer of Orthomet, Inc. (NASDAQ: OMET), announced that James C. Hawley has been named the company's executive vice president by its board of directors.
 Nikolaev said that Hawley's duties will not change, but "his new title more accurately reflects his role as Orthomet's operational leader." Hawley has responsibility for the company's finance, manufacturing, quality assurance, human resources, information systems and corporate communications functions.
 He joined the company as vice president and chief financial officer in May 1991, and was named senior vice president earlier this year when he was assigned broader responsibilities.
 Hawley previously had been with 3M for 11 years in various financial management positions, and was group controller for the Pharmaceutical and Dental Products Group at the time he left. He is a graduate of the University of Minnesota. His professional affiliations include serving on the board of directors of the Minnesota Society of Certified Public Accountants.
 Orthomet also announced that an important addition to its product line, the Posterior Stabilized Knee (PSK), has now been approved for marketing by the U.S. Food and Drug Administration. Along with its new Curved Tibial Insert that was released to the market this spring, the PSK completes Orthomet's product line for first time total knee replacements. The company will release the PSK to the marketplace at the conclusion of an expanded clinical investigation.
 Orthomet designs, manufactures and markets selected orthopaedic reconstructive implant products and related surgical instrumentation.
 -0- 8/31/92
 /CONTACT: James C. Hawley, Senior Vice President Finance & Operations and Chief Financial Officer of Orthomet, 612-944-6112/
 (OMET) CO: Orthomet, Inc. ST: Minnesota IN: MTC SU: PER


KH -- MN010 -- 5152 08/31/92 17:34 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 31, 1992
Words:303
Previous Article:AMERICAN STOCK EXCHANGE DAILY REPORT
Next Article:PENNSYLVANIA HOUSING FINANCE AGENCY EXTENDS MORTGAGE PROGRAM; PROVIDENT NATIONAL BANK CONTINUES TO ACCEPT LOAN APPLICATIONS
Topics:


Related Articles
ORTHOMET, INC. ADDS DIRECTOR
ORTHOMET ADDS VICE PRESIDENT, SALES
ORTHOMET ANNOUNCES APPOINTMENT OF CHAIRMAN AND CEO
ORTHOMET ANNOUNCES EXECUTIVE CHANGES
ORTHOMET NAMES NEW NATIONAL SALES MANAGER
ORTHOMET NAMES HAWLEY EXECUTIVE VICE PRESIDENT; ANNOUNCES FDA HAS APPROVED IMPORTANT KNEE IMPLANT PRODUCT FOR MARKETING
ORTHOMET ANNOUNCES FIRST QUARTER RESULTS
EVEREST MEDICAL CORPORATION ANNOUNCES TWO NEW BOARD MEMBERS
ORTHOMET AND KIRSCHNER SIGN LETTER OF INTENT TO MERGE
ORTHOMET AND WRIGHT MEDICAL TECHNOLOGY, INC. SIGN LETTER OF INTENT TO MERGE

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters